captopril has been researched along with alprostadil in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (35.71) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 3 (21.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Ishimine, M; Machida, Y; Mimura, G; Murakami, K; Nagamine, F; Nakada, Y; Niisato, T; Oshiro, K; Shimabukuro, M | 1 |
Fettman, MJ; Wilke, WL | 1 |
Brognoli, M; Campisi, S; Comberti, E; Doregatti, C; Gargiulo, A; Ghielmi, S; Poiesi, C; Rondina, M; Usberti, M; Zaneboni, A | 1 |
Greenbaum, LM; Sugio, K | 1 |
Friedman, WF; George, BL | 1 |
Connolly, SM | 1 |
Antunes, E; Brain, SD; de Nucci, G; Marangoni, RA | 1 |
Fischer, M; Marsch, WC; Wohlrab, J | 1 |
Kojima, F; Naraba, H; Narumiya, S; Oh-ishi, S; Ueno, A; Ushikubi, F; Yuhki, K | 1 |
2 review(s) available for captopril and alprostadil
Article | Year |
---|---|
Scleroderma: therapeutic options.
Topics: Alprostadil; Captopril; Colchicine; Griseofulvin; Humans; Immunosuppressive Agents; Nifedipine; Penicillamine; Phenytoin; Physical Therapy Modalities; Plasmapheresis; Prostaglandins E; Scleroderma, Systemic; Vasodilator Agents | 1984 |
[Current therapy of Sneddon's syndrome].
Topics: Alprostadil; Antihypertensive Agents; Blood Circulation; Captopril; Fibrinolytic Agents; Humans; Prognosis; Risk Factors; Smoking; Sneddon Syndrome; Ticlopidine | 2001 |
12 other study(ies) available for captopril and alprostadil
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[A case of recurrent syncope due to pulmonary embolism].
Topics: Alprostadil; Captopril; Cardiac Catheterization; Drug Therapy, Combination; Female; Humans; Middle Aged; Pulmonary Embolism; Recurrence; Syncope; Thrombolytic Therapy; Warfarin | 1992 |
Captopril or prostaglandin E1 ameliorate adverse renal hemodynamic effects of indomethacin in uninephrectomized rats.
Topics: Alprostadil; Animals; Blood Flow Velocity; Blood Pressure; Captopril; Drug Interactions; Glomerular Filtration Rate; Hemodynamics; Indomethacin; Kidney; Male; Nephrectomy; Rats; Rats, Inbred Strains; Vascular Resistance | 1989 |
Effect of exogenous prostaglandin E2 on plasma antidiuretic hormone in normal man. Role of angiotension II.
Topics: Adult; Aldosterone; Alprostadil; Blood Pressure; Captopril; Catecholamines; Drug Therapy, Combination; Humans; Kidney Function Tests; Male; Radioimmunoassay; Renin; Vasopressins | 1989 |
Increase in vascular permeability of rat and guinea pig skin by T-kinin.
Topics: Alprostadil; Animals; Bradykinin; Capillary Permeability; Captopril; Colforsin; Dose-Response Relationship, Drug; Exudates and Transudates; Guinea Pigs; Rats; Rats, Inbred Strains; Skin | 1988 |
Treatment of cardiac failure in infants.
Topics: Alprostadil; Captopril; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Indomethacin; Infant; Infant, Newborn; Nitroglycerin; Nitroprusside | 1986 |
Activation by Phoneutria nigriventer (armed spider) venom of tissue kallikrein-kininogen-kinin system in rabbit skin in vivo.
Topics: Alprostadil; Animals; Bradykinin; Capillary Permeability; Captopril; Edema; Histamine; Kallikrein-Kinin System; Kallikreins; Kininogens; Male; Rabbits; Receptors, Bradykinin; Receptors, Neurotransmitter; Regional Blood Flow; Skin; Spider Venoms | 1993 |
Prostaglandin receptors EP2, EP3, and IP mediate exudate formation in carrageenin-induced mouse pleurisy.
Topics: Alprostadil; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Captopril; Carrageenan; Dinoprostone; Exudates and Transudates; Indomethacin; Kinetics; Mice; Mice, Knockout; Pleurisy; Prostaglandins; Quinolines; Receptors, Epoprostenol; Receptors, Prostaglandin E; Reverse Transcriptase Polymerase Chain Reaction | 2004 |